10x Genomics sued Element Biosciences over alleged patent infringement involving Element’s Aviti24 multiomic analysis platform. The complaint, filed in the District of Delaware, alleges Aviti24 infringes several 10x spatial technology patents licensed from Harvard University, including patents covering compositions and methods for analyte detection and selective amplicon sequencing methods. 10x is seeking monetary damages, attorneys’ fees, and a permanent injunction. An Element spokesperson said the company strongly disagrees with the allegations and plans to vigorously defend its technology, characterizing the lawsuit as part of a broader pattern of stifling innovation using the same patent portfolio. The case matters for spatial genomics vendors because it can affect customer confidence, product timelines, and commercialization strategies—particularly where platform offerings depend on fast deployment and compatibility with large-scale academic and translational studies.